Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to $1.8 million.

  • HealthLynked's Liabilities and Shareholders Equity fell 3602.41% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 4662.61%. This contributed to the annual value of $2.2 million for FY2024, which is 4806.27% down from last year.
  • Per HealthLynked's latest filing, its Liabilities and Shareholders Equity stood at $1.8 million for Q3 2025, which was down 3602.41% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, HealthLynked's Liabilities and Shareholders Equity registered a high of $13.0 million during Q3 2021, and its lowest value of $1.8 million during Q3 2025.
  • Its 5-year average for Liabilities and Shareholders Equity is $6.0 million, with a median of $5.5 million in 2023.
  • In the last 5 years, HealthLynked's Liabilities and Shareholders Equity soared by 37653.84% in 2021 and then crashed by 5716.78% in 2022.
  • Over the past 5 years, HealthLynked's Liabilities and Shareholders Equity (Quarter) stood at $10.7 million in 2021, then plummeted by 57.17% to $4.6 million in 2022, then dropped by 6.56% to $4.3 million in 2023, then tumbled by 48.06% to $2.2 million in 2024, then fell by 20.62% to $1.8 million in 2025.
  • Its Liabilities and Shareholders Equity was $1.8 million in Q3 2025, compared to $1.8 million in Q2 2025 and $2.1 million in Q1 2025.